Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 2 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 2

From: Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation

Fig. 2

A 54-year-old male patient with Hodgkin’s lymphoma, treated with anti-cd20 antibody rituximab 4 months prior to vaccination. A Coronal and C axial CECT images revealed multiple enlarged left axillary LNs, largest measures 2.7 cm. B Coronal and D axial PET-CT images revealed enlarged and FDG-avid left axillary LNs of 3 SUVmax. At first, this was diagnosed as progression, ultrasound-guided biopsy-revealed reactive follicular hyperplasia with no malignancy. Clinical history revealed that he got the 2nd dose of Pfizer-BioNTech COVID-19 vaccine in his left arm 7 days before PET-CT study

Back to article page